IMARX THERAPEUTICS INC Development Agreements
8 Contracts & Agreements
- the possibility of delays in, adverse results of, and excessive costs of the development process (Filed With SEC on May 21, 2010)
- the possibility of delays in, adverse results of, and excessive costs of the development process (Filed With SEC on May 21, 2010)
- the possibility of delays in, adverse results of, and excessive costs of the development process (Filed With SEC on May 21, 2010)
- the possibility of delays in, adverse results of, and excessive costs of the development process (Filed With SEC on May 21, 2010)
- the possibility of delays in, adverse results of, and excessive costs of the development process (Filed With SEC on May 21, 2010)
- the possibility of delays in, adverse results of, and excessive costs of the development process (Filed With SEC on May 21, 2010)
- the possibility of delays in, adverse results of, and excessive costs of the development process (Filed With SEC on May 21, 2010)
- Obtain additional funding and/or enter into strategic partnerships to gain access to the required operating capital to continue the development of our SonoLysis program, and (Filed With SEC on March 9, 2009)